News Releases

NEWS RELEASES

GWG Holdings Receives Nasdaq Notification of Non-Compliance
MINNEAPOLIS , May 23, 2019 (GLOBE NEWSWIRE) -- GWG Holdings , Inc. (Nasdaq: GWGH) today announced that it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market on May 17, 2019 , informing the Company that it was not in compliance with the filing requirements for
The Beneficient Company Group and GWG Holdings Complete Expansion of their Strategic Relationship
DALLAS and MINNEAPOLIS, April 29, 2019 (GLOBE NEWSWIRE) -- The Beneficient Company Group, L.P. (BEN) and GWG Holdings, Inc. (Nasdaq: GWGH) reported today that they have completed the previously announced expansion of their strategic relationship, a transformational event for both organizations that
GWG Holdings Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
MINNEAPOLIS , April 22, 2019 (GLOBE NEWSWIRE) -- GWG Holdings , Inc. (Nasdaq: GWGH) today announced that it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market  on April 16, 2019 , informing the Company that it was not in compliance with the filing requirements
GWG Holdings and The Beneficient Company Announce Significant Expansion of Strategic Relationship
Accelerates GWG’s growth, financial capability and diversification Accelerates BEN’s efforts to build the most comprehensive and innovative liquidity provider for alternative asset investors   BEN and certain of its founders to acquire all of Jon and Steven Sabes’ Interest in GWG Holdings GWG CEO
GWG Holdings Announces New Life Expectancy Methodology
Results from Life Expectancy Providers Announced Updates and Changes Life Expectancy tables Significantly Improves Actual-to-Expected Predictive Power   Implementation Results in a Non-Cash, Non-Recurring Charge of $84 million in Q4 2018 MINNEAPOLIS, April 16, 2019 (GLOBE NEWSWIRE) -- GWG Holdings,
Life Epigenetics CEO Jon Sabes to Present at ReFocus Conference 2019 on March 11
MINNEAPOLIS, March 07, 2019 (GLOBE NEWSWIRE) -- Life Epigenetics , a biotechnology company that discovers, quantifies and commercializes epigenetic signatures for use in the longevity, clinical research, pharmaceutical, and nutraceutical markets, announced that its Chief Executive Officer Jon Sabes
GWG Holdings and The Beneficient Company Complete Their Transaction
MINNEAPOLIS , Dec. 28, 2018 (GLOBE NEWSWIRE) -- GWG Holdings , Inc. (Nasdaq: GWGH ) reported today that it has completed its strategic transaction with The Beneficient Company Group, L.P. (BEN) and other parties. As a result of the final closing, GWGH holds 40,505,279 common units of BEN and a $193
GWG Holdings Endorses Federal Legislation Allowing Seniors to Use Life Insurance Proceeds for Long-Term Care Costs Tax-Free
Potential Law Would Save Billions for Taxpayers, Improve Quality of Life for Millions of Seniors Minneapolis, Dec. 13, 2018 (GLOBE NEWSWIRE) -- GWG Holdings (NASDAQ:GWGH) announced its endorsement of a new piece of federal legislation that, for the first time, would enable seniors to sell life
GWG Holdings Clears Final Regulatory Hurdle for Transaction with The Beneficient Company
MINNEAPOLIS , Dec. 06, 2018 (GLOBE NEWSWIRE) -- GWG Holdings , Inc. (Nasdaq: GWGH ) announced today that it has received clearance from the Securities and Exchange Commission ( SEC ) to file with the SEC and mail to its stockholders a definitive Information Statement on Schedule 14C relating to its
GWG Holdings Reports Results for the Third Quarter Ended September 30, 2018
GWGH Announces share repurchase program MINNEAPOLIS , Nov. 19, 2018 (GLOBE NEWSWIRE) -- GWG Holdings, Inc. (Nasdaq:GWGH), a leading provider of liquidity to consumers owning life insurance policies, an owner of a portfolio of alternative assets, and the developer of epigenetic technology for the